Prescribing in Parkinson's disease: a story of hope and adverse events

Pract Neurol. 2012 Oct;12(5):335-40.

Morrish P.

Abstract

A review of National Health Service spending in England on prescription drugs used in Parkinsonism over the last 10 years shows that spending has risen rapidly and that newly introduced drugs are quickly and expensively adopted. This paper explores the gains and costs of such prescribing.

Posted with Blogsy